Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2011 1
2012 2
2013 1
2014 4
2015 2
2016 6
2017 4
2018 2
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.
Dworkin RH, Allen R, Kopko S, Lu Y, Turk DC, Burke LB, Desjardins P, Etropolski M, Hewitt DJ, Jayawardena S, Lin AH, Malamut R, Michel D, Ottinger J, Peloso P, Pucino F, Rappaport BA, Skljarevski V, St Peter D, Timinski S, West CR, Wilson HD. Dworkin RH, et al. Among authors: jayawardena s. Pain. 2013 Jan;154(1):11-14. doi: 10.1016/j.pain.2012.10.014. Epub 2012 Oct 26. Pain. 2013. PMID: 23218970 Review. No abstract available.
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history.
Corren J, Castro M, Ford LB, Bernstein JA, Jayawardena S, Maroni J, Rowe P, Amin N, Pirozzi G, Graham NMH, Khan A, Eckert L, Teper A. Corren J, et al. Among authors: jayawardena s. Ann Allergy Asthma Immunol. 2019 Aug;123(2):222-224.e1. doi: 10.1016/j.anai.2019.04.028. Epub 2019 May 8. Ann Allergy Asthma Immunol. 2019. PMID: 31075309 Free article. No abstract available.
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.
Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A. Weinstein SF, et al. Among authors: jayawardena s. J Allergy Clin Immunol. 2018 Jul;142(1):171-177.e1. doi: 10.1016/j.jaci.2017.11.051. Epub 2018 Jan 31. J Allergy Clin Immunol. 2018. PMID: 29355679 Free article. Clinical Trial.
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
de Bruin-Weller M, Pink AE, Ferrucci SM, Patrizi A, Svensson A, Schuttelaar MLA, Tauber M, Ardeleanu M, Jayawardena S, Daoud M. de Bruin-Weller M, et al. Among authors: jayawardena s. J Dermatolog Treat. 2022 Aug;33(5):2565-2570. doi: 10.1080/09546634.2022.2038361. Epub 2022 Mar 8. J Dermatolog Treat. 2022. PMID: 35255779
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
Bruin-Weller M, Pink AE, Patrizi A, Gimenez-Arnau AM, Agner T, Roquet-Gravy PP, Ferrucci SM, Arenberger P, Svensson A, Schuttelaar MLA, Nosbaum A, Jayawardena S, Rizova E, Ardeleanu M, Eckert L, Ozturk ZE. Bruin-Weller M, et al. Among authors: jayawardena s. J Dermatolog Treat. 2021 Mar;32(2):164-173. doi: 10.1080/09546634.2020.1866741. Epub 2021 Jan 18. J Dermatolog Treat. 2021. PMID: 33461356
Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology.
Paller AS, Guttman-Yassky E, Irvine AD, Baselga E, de Bruin-Weller M, Jayawardena S, Zhang A, Mina-Osorio P, Rizova E, Ozturk ZE. Paller AS, et al. Among authors: jayawardena s. BMJ Open. 2020 Mar 24;10(3):e033507. doi: 10.1136/bmjopen-2019-033507. BMJ Open. 2020. PMID: 32209624 Free PMC article.
21 results